Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met

<p>The results of the study will support the Company’s IDE submission to the FDA to commence its human clinical study BRAINTREE, Mass., Dec. 28, 2023 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announces the successful completion of its GLP pivotal pre-clinical study, done under […]</p>
<p>The post <a href="https://forextv.com/top-news/microbot-medical-announced-positive-results-of-its-glp-pivotal-pre-clinical-study-where-all-study-objectives-were-met/">Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>